MACOM Technology Solutions Free cash flow increased by 118.3% to $65.47M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 114.5%, from $30.53M to $65.47M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 10.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.50M | $39.28M | $35.78M | $29.01M | $35.40M | $33.76M | $52.30M | $28.66M | $26.48M | $42.54M | $44.55M | $28.45M | $13.07M | $41.54M | $57.14M | $61.32M | $30.53M | $51.55M | $49.42M | $29.99M | $65.47M |
| QoQ Change | — | +67.1% | -8.9% | -18.9% | +22.0% | -4.6% | +54.9% | -45.2% | -7.6% | +60.7% | +4.7% | -36.1% | -54.0% | +217.7% | +37.6% | +7.3% | -50.2% | +68.9% | -4.1% | -39.3% | +118.3% |
| YoY Change | — | — | — | — | +50.6% | -14.1% | +46.2% | -1.2% | -25.2% | +26.0% | -14.8% | -0.7% | -50.6% | -2.4% | +28.3% | +115.6% | +133.5% | +24.1% | -13.5% | -51.1% | +114.5% |